HJGA
PFE icon

Hardman Johnston Global Advisors’s Pfizer PFE Stock Holding History

Hardman Johnston Global Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$665K Hold
27,600
– – 0.02% 67
2026
Q1 		$775K Buy
+27,600
New +$735K 0.04% 62
2022
Q1 		– Sell
-3,600
Closed -$213K – 80
2021
Q4 		$213K Buy
+3,600
New +$178K 0.01% 75

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Hardman Johnston Global Advisors's PFE Position: Q2 2026 in Review

Hardman Johnston Global Advisors held its Pfizer (PFE) position steady in Q2 2026 at 27,600 shares worth $665K. The position accounts for 0.02% of the portfolio, ranked #67.

Hardman Johnston Global Advisors first reported a position in PFE in Q4 2021 and has held it in 3 quarters since. The position peaked at $775K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Hardman Johnston Global Advisors held 27,600 shares of Pfizer worth $665K as of Q2 2026.
  • Hardman Johnston Global Advisors left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.02% of Hardman Johnston Global Advisors's portfolio in Q2 2026, its #67 holding.
  • Hardman Johnston Global Advisors first reported a position in Pfizer in Q4 2021 and has held it in 3 quarters since.
  • Hardman Johnston Global Advisors's Pfizer position peaked at $775K in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hardman Johnston Global Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.